| Full name: solute carrier family 35 member G3 | Alias Symbol: FLJ40154 | ||
| Type: protein-coding gene | Cytoband: 17q12 | ||
| Entrez ID: 146861 | HGNC ID: HGNC:26848 | Ensembl Gene: ENSG00000164729 | OMIM ID: |
| Drug and gene relationship at DGIdb | |||
Expression of SLC35G3:
| Dataset | Gene | EntrezID | Probe | Log2FC | Adj.pValue | Expression |
|---|---|---|---|---|---|---|
| GSE17351 | SLC35G3 | 146861 | 1553471_at | -0.1025 | 0.7123 | |
| GSE26886 | SLC35G3 | 146861 | 1553471_at | -0.1968 | 0.0426 | |
| GSE45670 | SLC35G3 | 146861 | 1553471_at | -0.0767 | 0.4353 | |
| GSE53622 | SLC35G3 | 146861 | 138643 | 0.6314 | 0.0002 | |
| GSE53624 | SLC35G3 | 146861 | 138643 | 1.2203 | 0.0000 | |
| GSE63941 | SLC35G3 | 146861 | 1553471_at | 0.0939 | 0.5311 | |
| GSE77861 | SLC35G3 | 146861 | 1553471_at | -0.0056 | 0.9807 |
Upregulated datasets: 1; Downregulated datasets: 0.
Survival by SLC35G3 expression:
Note: Click image to view full size file.
Copy number change of SLC35G3:
| Dataset | Gene | EntrezID | Gain | Loss | Normal | Detail |
|---|---|---|---|---|---|---|
| GSE15526 | SLC35G3 | 146861 | 5 | 1 | 24 | |
| GSE20123 | SLC35G3 | 146861 | 5 | 1 | 24 | |
| GSE43470 | SLC35G3 | 146861 | 1 | 2 | 40 | |
| GSE46452 | SLC35G3 | 146861 | 34 | 0 | 25 | |
| GSE47630 | SLC35G3 | 146861 | 7 | 1 | 32 | |
| GSE54993 | SLC35G3 | 146861 | 3 | 3 | 64 | |
| GSE54994 | SLC35G3 | 146861 | 8 | 6 | 39 | |
| GSE60625 | SLC35G3 | 146861 | 4 | 0 | 7 | |
| GSE74703 | SLC35G3 | 146861 | 1 | 1 | 34 | |
| GSE74704 | SLC35G3 | 146861 | 3 | 1 | 16 | |
| TCGA | SLC35G3 | 146861 | 20 | 9 | 67 |
Total number of gains: 91; Total number of losses: 25; Total Number of normals: 372.
Somatic mutations of SLC35G3:
Generating mutation plots.
Highly correlated genes for SLC35G3:
Showing all 3 correlated genes with mean PCC>0.5.
| Gene1 | Gene2 | Mean PCC | Num. Datasets | Num. PCC<0 | Num. PCC>0.5 |
|---|---|---|---|---|---|
| SLC35G3 | LINC01231 | 0.560244 | 3 | 0 | 3 |
| SLC35G3 | CHIC2 | 0.555425 | 3 | 0 | 3 |
| SLC35G3 | NR5A1 | 0.509276 | 4 | 0 | 3 |
For details and further investigation, click here

